Michael Charlton to Intention to Treat Analysis
This is a "connection" page, showing publications Michael Charlton has written about Intention to Treat Analysis.
Connection Strength
0.036
-
Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial. Lancet Gastroenterol Hepatol. 2016 10; 1(2):122-132.
Score: 0.036